ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,164.12
-0.19%
Dow Jones
39,118.86
-0.12%
Gold vs US Dollar
2,326.73
0.00%
Brent Oil
84.85
0.00%
Bitcoin
60,941.30
1.04%
Pepperstone
Advertisement
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Get Started
  1. Home
  2. Investing
  3. ETFs
  4. USA
  5. AMEX
  6. Emles at Home ETF (LIV)

  7. Emles at Home ETF (LIV) News

Emles at Home ETF (LIV)

Emles at Home ETF
Date:
Sort by:
 Showing the most relevant articles for your search:AMEX:LIV
DateTimeSourceHeadlineSymbolCompany
16/09/202222:00PR Newswire (US)Emles Advisors Announces Closure of Six FundsAMEX:LIVEmles at Home ETF
13/12/200715:15Edgar (US Regulatory)Samaritan Pharmaceuticals Inc - Current report filing (8-K)AMEX:LIVEmles at Home ETF
27/11/200714:17Edgar (US Regulatory)Samaritan Pharmaceuticals Inc - Current report filing (8-K)AMEX:LIVEmles at Home ETF
19/11/200717:52Edgar (US Regulatory)Samaritan Pharmaceuticals Inc - Quarterly Report (10-Q)AMEX:LIVEmles at Home ETF
15/11/200719:16Edgar (US Regulatory)Samaritan Pharmaceuticals Inc - Notification that Quarterly Report will be submitted late (NT 10-Q)AMEX:LIVEmles at Home ETF
13/11/200711:06Edgar (US Regulatory)Samaritan Pharmaceuticals Inc (Other)AMEX:LIVEmles at Home ETF
08/11/200715:06Edgar (US Regulatory)Samaritan Pharmaceuticals Inc - Current report filingAMEX:LIVEmles at Home ETF
03/10/200714:54Edgar (US Regulatory)Samaritan Pharmaceuticals Inc - Current report filing (8-K)AMEX:LIVEmles at Home ETF
03/10/200714:54Edgar (US Regulatory)Samaritan Pharmaceuticals Inc - Current report filing (8-K)AMEX:LIVEmles at Home ETF
01/10/200715:00Edgar (US Regulatory)Samaritan Pharmaceuticals Inc (Other) (8-K)AMEX:LIVEmles at Home ETF
28/09/200715:00Edgar (US Regulatory)Samaritan Pharmaceuticals Inc (Other) (8-K)AMEX:LIVEmles at Home ETF
21/09/200721:43Edgar (US Regulatory)Samaritan Pharmaceuticals Inc (Other) (8-K)AMEX:LIVEmles at Home ETF
20/09/200715:00Edgar (US Regulatory)Samaritan Pharmaceuticals Inc (Other) (8-K)AMEX:LIVEmles at Home ETF
18/09/200714:10Edgar (US Regulatory)Samaritan Pharmaceuticals Inc - Current report filing (8-K)AMEX:LIVEmles at Home ETF
15/06/200615:09Business WireSamaritan to Initiate Phase III Clinical Trial in Europe to Accelerate Development Timeline of Its HIV Oral Entry Inhibitor SP0AMEX:LIVEmles at Home ETF
30/05/200613:59Business WireSamaritan Reports Positive Preliminary Results with ''Oral'' HIV Entry Inhibitor in Phase II 10-Day HIV Monotherapy TrialAMEX:LIVEmles at Home ETF
23/05/200614:22Business WireSamaritan Files Provisional Patent to Support Promising New Type of Anti-cholesterol Drug SP-1000 and Cover Additional Claims;AMEX:LIVEmles at Home ETF
02/05/200614:15Business WireSamaritan Starts Enrolling for Its PII Stage 2 (28 Day Monotherapy) Study of ''Oral'' Entry Inhibitor SP-01AAMEX:LIVEmles at Home ETF
25/04/200613:00Business WireSIS Foundation Driven to Drive Bio Future Bus So Kids Can Speed up Science Innovation; Only 17% of US Students Graduate with ScAMEX:LIVEmles at Home ETF
13/04/200618:13Business WireBio 2006 Analysts Predict Small-Cap Biotechs to Outperform Large-Caps This YearAMEX:LIVEmles at Home ETF
06/04/200613:30Business WireLIV to Host Annual Shareholders MeetingAMEX:LIVEmles at Home ETF
04/04/200614:15Business WireSamaritan's Marketing Authorization Application For Amphocil Approved in GreeceAMEX:LIVEmles at Home ETF
30/03/200615:15Business WireSamaritan to Present Its Drugs and Diagnostics for Partnering at BIO 2006 Annual International ConferenceAMEX:LIVEmles at Home ETF
28/03/200615:27Business WireNew Preclinical Data Shows Samaritan's Cardiovascular Drug Reduces Cholesterol; Cardiovascular Disease is a $15B Market WorldwiAMEX:LIVEmles at Home ETF
23/03/200614:30Business WireSamaritan is the Little Biotech That Could Be Remembered for Alzheimer'sAMEX:LIVEmles at Home ETF
22/03/200604:01Business WireCORRECTING and REPLACING Samaritan's Adult Stem Cell Drug Displays Money-Making SignsAMEX:LIVEmles at Home ETF
21/03/200615:29Business WireSamaritan's Adult Stem Cell Drug Displays Money-Making SignsAMEX:LIVEmles at Home ETF
09/03/200613:00Business WireUPDATE: Samaritan Kicks Off Follow-On HIV StudyAMEX:LIVEmles at Home ETF
01/03/200613:00Business WireDistinguished Cancer Drug Developer Joins Samaritan Scientific Advisory BoardAMEX:LIVEmles at Home ETF
28/02/200613:00Business WireSamaritan's Alzheimer's Drug Registered as CAPROSPINOL; SP-233 (Caprospinol) is Believed to Exhibit Neuroprotective PropertiesAMEX:LIVEmles at Home ETF
 Showing the most relevant articles for your search:AMEX:LIV

Your Recent History

COIN
BOLIUSD
LSE
JT70
Citi Fun 25
BIT
UB48GM
Unicredit Bank
NYSE
OXM
Oxford Industries
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved